Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)

South Korea · Delayed Price · Currency is KRW

4,845.00

+95.00 (2.00%)

At close: Jul 31, 2026

Kyung Dong Pharmaceutical Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	198,275	196,273	193,936	162,674	182,718	177,611
Revenue Growth	1.85%	1.21%	19.22%	-10.97%	2.88%	2.18%
Gross Profit	118,455	117,101	114,365	89,344	95,910	98,082
Operating Income	8,547	7,666	2,624	-24,955	8,312	15,758
Net Income	11,633	8,529	5,470	-20,708	12,161	12,672
Earnings Per Share	426.02	315.00	203.00	-763.17	446.96	460.42
EPS Growth	97.06%	55.17%	-	-	-2.92%	-9.33%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	29,368	46,998	30,913	32,075	45,128	50,043
Total Debt	25,536	45,443	38,677	15,373	26,869	4,329
Net Cash (Debt)	3,832	1,554	-7,764	16,701	18,259	45,714
Net Cash Growth	-	-	-	-8.53%	-60.06%	-23.28%
Net Cash Per Share	140.11	57.28	-288.15	615.52	671.07	1660.97

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	17,090	16,934	-8,074	-31.94	-1,075	12,422
Capital Expenditures	-17,143	-18,394	-7,618	-6,290	-10,574	-3,926
Free Cash Flow	-52.77	-1,460	-15,692	-6,322	-11,649	8,496
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	59.74%	59.66%	58.97%	54.92%	52.49%	55.22%
Operating Margin	4.31%	3.91%	1.35%	-15.34%	4.55%	8.87%
Pretax Margin	6.68%	4.65%	2.69%	-11.37%	9.82%	10.38%
Profit Margin	5.87%	4.35%	2.82%	-12.73%	6.66%	7.13%
FCF Margin	-0.03%	-0.74%	-8.09%	-3.89%	-6.38%	4.78%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	300.000	-	-	-	400.000	500.000
Dividend Per Share Growth	0%	-	-	-	-20.00%	0%
Dividend Yield	6.19%	-	-	-	5.96%	5.38%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	11.37	18.45	30.19	-	17.56	24.74
Forward PE	-	12.11	12.11	12.11	12.11	12.11
P/FCF Ratio	-	-	-	-	-	36.90
PS Ratio	0.66	0.80	0.85	1.10	1.17	1.77